Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (101-110 of 601) with videos related to

Pageof 61
Sort By:
Nature Clinical Practice. Neurology|August 26, 2006
Immunopathogenesis and immunotherapy of multiple sclerosisBernhard Hemmer, Stefan Nessler, Dun Zhou, et al.
Nature Reviews. Disease Primers|October 13, 2018
Immune-mediated neuropathiesBernd C Kieseier, Emily K Mathey, Claudia Sommer, et al.
Experimental Neurology|July 24, 2007
Development and pharmacological modulation of embryonic stem cell-derived neuronal network activitySebastian Illes, Wiebke Fleischer, Mario Siebler, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2010
Differential patterns of local gene regulation in crush lesions of the rat optic and sciatic nerve: relevance to posttraumatic regenerationPhilipp Zickler, Patrick Küry, Michael Gliem, et al.
Experimental Neurology|May 11, 2015
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotypeAndré Heinen, Felix Beyer, Nevena Tzekova, et al.
Expert Review of Neurotherapeutics|August 24, 2016
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosisTil Menge, Divyanshu Dubey, Clemens Warnke, et al.
Journal of Neurology|January 9, 2022
Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod-potentials and risks of subsequent highly active agentsMelanie Korsen, Steffen Pfeuffer, Leoni Rolfes, et al.
Nature Reviews. Neurology|April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseasesAlexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Trends in Neurosciences|February 20, 2002
Autoimmunity and inflammation in the peripheral nervous systemHugh Willison, Guido Stoll, Klaus V Toyka, et al.
Plos One|December 14, 2012
Age-dependent modulation of cortical transcriptomes in spinal cord injury and repairAnne Jaerve, Fabian Kruse, Katharina Malik, et al.
Pageof 61

Showing results (101-110 of 601) with videos related to

Sort By:
Pageof 61
Nature Clinical Practice. Neurology|August 26, 2006
Immunopathogenesis and immunotherapy of multiple sclerosisBernhard Hemmer, Stefan Nessler, Dun Zhou, et al.
Nature Reviews. Disease Primers|October 13, 2018
Immune-mediated neuropathiesBernd C Kieseier, Emily K Mathey, Claudia Sommer, et al.
Experimental Neurology|July 24, 2007
Development and pharmacological modulation of embryonic stem cell-derived neuronal network activitySebastian Illes, Wiebke Fleischer, Mario Siebler, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2010
Differential patterns of local gene regulation in crush lesions of the rat optic and sciatic nerve: relevance to posttraumatic regenerationPhilipp Zickler, Patrick Küry, Michael Gliem, et al.
Experimental Neurology|May 11, 2015
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotypeAndré Heinen, Felix Beyer, Nevena Tzekova, et al.
Expert Review of Neurotherapeutics|August 24, 2016
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosisTil Menge, Divyanshu Dubey, Clemens Warnke, et al.
Journal of Neurology|January 9, 2022
Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod-potentials and risks of subsequent highly active agentsMelanie Korsen, Steffen Pfeuffer, Leoni Rolfes, et al.
Nature Reviews. Neurology|April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseasesAlexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Trends in Neurosciences|February 20, 2002
Autoimmunity and inflammation in the peripheral nervous systemHugh Willison, Guido Stoll, Klaus V Toyka, et al.
Plos One|December 14, 2012
Age-dependent modulation of cortical transcriptomes in spinal cord injury and repairAnne Jaerve, Fabian Kruse, Katharina Malik, et al.
Pageof 61